Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperlipidemias | 1 | 2023 | 770 | 0.630 |
Why?
|
| Medicare Part D | 1 | 2022 | 354 | 0.560 |
Why?
|
| Medicare Part C | 1 | 2022 | 329 | 0.540 |
Why?
|
| Hypertension | 4 | 2023 | 8529 | 0.500 |
Why?
|
| Hypercholesterolemia | 1 | 2022 | 1141 | 0.480 |
Why?
|
| Prescription Drugs | 1 | 2022 | 631 | 0.470 |
Why?
|
| Osteoarthritis | 1 | 2022 | 1063 | 0.450 |
Why?
|
| Osteoporosis | 1 | 2022 | 1604 | 0.400 |
Why?
|
| Hospitals | 1 | 2021 | 3877 | 0.300 |
Why?
|
| Atrial Fibrillation | 2 | 2024 | 5031 | 0.280 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3204 | 0.280 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5835 | 0.260 |
Why?
|
| Registries | 1 | 2021 | 8207 | 0.250 |
Why?
|
| China | 4 | 2023 | 2374 | 0.210 |
Why?
|
| Stroke | 2 | 2024 | 9712 | 0.200 |
Why?
|
| Hospitalization | 1 | 2021 | 10704 | 0.190 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2024 | 452 | 0.170 |
Why?
|
| Nutrition Surveys | 2 | 2023 | 1723 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 12142 | 0.150 |
Why?
|
| Heart Failure | 1 | 2022 | 11669 | 0.140 |
Why?
|
| Drug Approval | 1 | 2024 | 812 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2023 | 1469 | 0.140 |
Why?
|
| Retinal Detachment | 1 | 2020 | 428 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2024 | 1661 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 26049 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2018 | 959 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2024 | 2008 | 0.110 |
Why?
|
| Drug Costs | 1 | 2022 | 1183 | 0.110 |
Why?
|
| Survivors | 1 | 2023 | 2372 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 924 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 3730 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2018 | 868 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2023 | 8472 | 0.090 |
Why?
|
| Retina | 1 | 2020 | 2655 | 0.080 |
Why?
|
| Health Expenditures | 1 | 2022 | 2361 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2024 | 4785 | 0.080 |
Why?
|
| United States | 4 | 2024 | 72272 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5293 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 2916 | 0.070 |
Why?
|
| Aged | 5 | 2023 | 169042 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2022 | 9311 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4431 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2018 | 1846 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 8998 | 0.060 |
Why?
|
| Incidence | 1 | 2021 | 21337 | 0.050 |
Why?
|
| Tremor | 1 | 2023 | 190 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2022 | 80566 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39063 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 39913 | 0.050 |
Why?
|
| Vibration | 1 | 2023 | 328 | 0.050 |
Why?
|
| Australia | 1 | 2024 | 1248 | 0.050 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2016 | 0.050 |
Why?
|
| Myelin Proteins | 1 | 2020 | 209 | 0.040 |
Why?
|
| Pyridones | 1 | 2024 | 808 | 0.040 |
Why?
|
| Canada | 1 | 2024 | 2118 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 6403 | 0.040 |
Why?
|
| Risk Factors | 2 | 2023 | 74115 | 0.040 |
Why?
|
| Humans | 8 | 2024 | 760617 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2020 | 251 | 0.040 |
Why?
|
| Male | 5 | 2023 | 360358 | 0.040 |
Why?
|
| Female | 5 | 2023 | 392148 | 0.040 |
Why?
|
| Thiazoles | 1 | 2024 | 1517 | 0.040 |
Why?
|
| Young Adult | 1 | 2023 | 59179 | 0.030 |
Why?
|
| Receptors, Fc | 1 | 2020 | 534 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2024 | 4010 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2020 | 653 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 796 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2018 | 933 | 0.030 |
Why?
|
| Hypolipidemic Agents | 1 | 2018 | 609 | 0.030 |
Why?
|
| Pyridines | 1 | 2024 | 2874 | 0.030 |
Why?
|
| Axons | 1 | 2020 | 1671 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15498 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2020 | 1807 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 220584 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18221 | 0.020 |
Why?
|
| Motor Activity | 1 | 2020 | 2714 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2978 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 220969 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3332 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4668 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5332 | 0.020 |
Why?
|
| Health Status | 1 | 2018 | 4075 | 0.020 |
Why?
|
| Rats | 1 | 2020 | 23717 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3879 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6390 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 4007 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14591 | 0.010 |
Why?
|
| Neurons | 1 | 2020 | 9438 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15689 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2018 | 12943 | 0.010 |
Why?
|
| Animals | 2 | 2020 | 168201 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29600 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 13347 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23972 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2018 | 15612 | 0.010 |
Why?
|
| Obesity | 1 | 2018 | 12933 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 54360 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81368 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 64568 | 0.010 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_